[CAS NO. 147-85-3] L-Proline
PRODUCTS SPECIFICATIONS [147-85-3]
DESCRIPTION [147-85-3]
Overview
| MDL | MFCD00064318 |
|---|---|
| Molecular Weight | 115.13 |
| Molecular Formula | C5H9NO2 |
| SMILES | O=C(O)[C@H]1NCCC1 |
1 Publications Citing Use of MCE
Summary
L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins.
IC50 & Target
|
Human Endogenous Metabolite |
Microbial Metabolite |
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT02794792 | Astellas Pharma Europe B.V.|Astellas Pharma Inc |
Type 2 Diabetes Mellitus
|
May 11, 2016 | Phase 3 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Solvent & Solubility
H 2 O : 50 mg/mL ( 434.29 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 8.6858 mL | 43.4292 mL | 86.8583 mL |
| 5 mM | 1.7372 mL | 8.6858 mL | 17.3717 mL |
| 10 mM | 0.8686 mL | 4.3429 mL | 8.6858 mL |
-
1.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (868.58 mM); Clear solution; Need ultrasonic
Synonyms